Centessa Pharmaceuticals (CNTA)
15.37
0.53 (3.57%)
At close: Jan 15, 2025, 12:34 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -151.09M | -216.21M | -381.85M | -10.66M | -5.06M |
| Depreciation & Amortization | 810.00K | 131.00K | 33.99K | n/a | 6.00K |
| Stock-Based Compensation | 29.39M | 24.96M | 14.85M | 336.00K | 236.00K |
| Other Working Capital | -16.13M | -9.18M | 1.34M | -440.00K | -1.86M |
| Other Non-Cash Items | 6.03M | -3.75M | 257.85M | 186.00K | -770 |
| Deferred Income Tax | -26.63M | -2.86M | -6.80M | n/a | 770.00 |
| Change in Working Capital | -18.86M | -2.83M | -5.38M | -489.00K | -1.01M |
| Operating Cash Flow | -160.34M | -200.55M | -136.14M | -10.63M | -5.83M |
| Capital Expenditures | -169.00K | -1.14M | -185.98K | n/a | n/a |
| Acquisitions | n/a | n/a | 63.43M | n/a | n/a |
| Purchase of Investments | -264.91M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 138.07M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 206.00K | -1 | n/a | n/a |
| Investing Cash Flow | -127.00M | -931.00K | 63.25M | n/a | n/a |
| Debt Repayment | n/a | n/a | 73.93M | 1.36M | 3.83M |
| Common Stock Repurchased | n/a | n/a | -12.00K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 310.00K | 457.00K | 586.14M | 1K | 5.17M |
| Financial Cash Flow | 21.12M | 457.00K | 660.07M | 1.36M | 9.01M |
| Net Cash Flow | -265.61M | -201.44M | 590.08M | -9.34M | 3.70M |
| Free Cash Flow | -160.51M | -201.68M | -136.33M | -10.63M | -5.83M |